title: Treatment options in the young patient with Graves' disease.
abstract: The treatment options in the young patient with Graves' disease are the same as in adults, namely antithyroid drug (ATD), surgery (partial or total thyroidectomy) and radioiodine. However, the emphasis and expectation is different in the young person, reflecting a range of considerations including age, pubertal status, disease natural history, likely impact of ATD on disease course and the implications of radiation exposure. New therapeutic strategies that could increase the likelihood of long-term remission are being explored.
authors.affiliation: Department of Paediatric Endocrinology, c/o Old Children's Out Patients, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.|Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK.
authors.forename: Tim
authors.initials: T
authors.lastname: Cheetham
authors.affiliation: Department of Surgery, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.
authors.forename: Richard
authors.initials: R
authors.lastname: Bliss
mesh_terms: D000293:Adolescent; D013956:Antithyroid Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005260:Female; D006111:Graves Disease / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D011379:Prognosis; D013965:Thyroidectomy / Q000379:methods
chemical_list: D013956:Antithyroid Agents; D007457:Iodine Radioisotopes